首页> 外文期刊>Journal of oral pathology and medicine: Official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology >Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.
【24h】

Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.

机译:Ca(2 +)结合S-100蛋白S-100a1,S-100a2,S-100a4,S-100a6和S-100b的免疫组化评价在唾液腺肿瘤中。

获取原文
获取原文并翻译 | 示例
           

摘要

The Ca(2+)-binding S-100 proteins are involved in the regulation of a number of cellular processes and an altered expression has been reported in several neoplastic tissues. Tissue specimens of normal salivary glands (n = 23), pleomorphic adenomas (n = 60), basal cell adenomas (n = 6), canalicular ademomas (n = 2), myoepitheliomas (n = 2), adenoid cystic carcinomas (n = 26) and adenocarcinomas NOS (n = 11) were evaluated for the expression of S-100A1, S-100A2, A-100A4, S-100A6 and S-100B by using highly specific polyclonal and monoclonal antibodies generated against the recombinant human protein. In normal salivary glands, the ductal cells showed mild to intense immunoreactivity for S-100A1, S-100A2, S-100A4 and S-100A6, while S-100B was observed in nerve fibers in the connective tissue. The normal myoepithelial cells were unreactive. In pleomorphic adenoma, the luminal tumor cells of the duct-like structures showed moderate to intense immunoreactivity for S-100A2, while reactivity for S-100A1, S-100A4and S-100A6 was relatively weak. The non-luminal cells, also termed neoplastic myoepithelial cells, showed immunoreactivity for S-100B, while tumor cells in the solid, myxoid and chondroid areas were immunoreactive for S-100A1, S-100A4, S-100A6 and S-100B. The non-luminally located tumor cells in basal cell adenomas and canalicular adenomas, and numerous tumor cells in clusters in myoepitheliomas were intensely reactive for S-100A2. In adenoid cystic carcinomas and in adenocarcinomas not otherwise specified, the luminal cells forming the tubular or cribriform structures were markedly positive for S-100A2 and/or S-100A6. Squamous metaplastic cells in salivary tumors showed intense immunoreactivity for S-100A2. The results of the present study suggest that the majority of the tumor cells in salivary neoplasms, despite the most heterogeneous tumor cell differentiation, express S-100 proteins more heterogeneously than the normal glandular ducts. The salivary ducts in normal glands, the luminal tumor cells and squamous metaplastic cells in the neoplastic lesions were intensely immunoreactive for S-100A2 as compared to S-100A1, S-100A4 or S-100A6. In contrast, the non-luminal tumor cells showed a rather heterogeneous expression of the S-100 proteins.
机译:结合的S-100蛋白涉及许多细胞方法的调节,并且在几个肿瘤组织中报道了改变的表达。正常唾液腺的组织标本(n = 23),亲属性腺瘤(n = 60),基细胞腺瘤(n = 6),Canalicular adeMOMAs(n = 2),肌肌肌瘤(n = 2),腺样囊性癌(n = 26)通过使用针对重组人蛋白产生的高度特异性多克隆和单克隆抗体来评估S-100A1,S-100A2,A-100A4,S-100A6和S-100B的表达的腺癌NOS(n = 11)。在正常唾液腺中,导管细胞对于S-100A1,S-100A2,S-100A4和S-100A6显示温和的免疫反应性,而在结缔组织中的神经纤维中观察到S-100B。正常的肌肌上性细胞是非反应性的。在亲属性腺瘤中,管道状结构的腔肿瘤细胞显示出S-100A2的中等至强烈的免疫反应性,而S-100A1,S-100A4和S-100A6的反应性相对较弱。非腔细胞,也称为肿瘤肌上皮细胞,显示出S-100B的免疫反应性,而S-100A1,S-100A4,S-100A6和S-100B的固体,麦克酸和软骨区域中的肿瘤细胞是免疫的。在基底细胞腺瘤和肿瘤腺瘤中的非腔内定位肿瘤细胞,以及肌上溶胶中的许多肿瘤细胞对于S-100a2强烈反应性。在腺样囊性癌和未另行指定的腺癌中,形成管状或碎屑结构的腔细胞对于S-100A2和/或S-100A6显着阳性。唾液肿瘤中的鳞状细胞表现出S-100A2的强烈免疫反应性。本研究结果表明,唾液肿瘤中大多数肿瘤细胞,尽管最均匀的肿瘤细胞分化,但表达S-100蛋白更加异常,而不是正常的腺体管。与S-100A1,S-100A4或S-100A6相比,正常腺体中的唾液管,肿瘤肿瘤细胞和肿瘤病变中的肿瘤瘤细胞和鳞状细胞的鳞状病变强烈反应,与S-100A2相比。相反,非腔肿瘤细胞显示出S-100蛋白的相当异质表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号